AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT inhibition in prostate cancer.CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Mar 31, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium

0:00 1:29:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Prostate Cancer Update?

This episode is 1 hour and 29 minutes long.

When was this Prostate Cancer Update episode published?

This episode was published on March 31, 2026.

Can I download this Prostate Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!